Spirulina

PreclinicalSmall molecule

TTanta University

Spirulina is one of 42 small molecule programs targeting Beta-Thalassemia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Beta-ThalassemiaActive, not recruiting

PeriodontitisActive, not recruiting

Beta-ThalassemiaPreclinical

Active, not recruiting

PeriodontitisPreclinical

Active, not recruiting

Competition

Competitive Landscape

34 competitors in Periodontitis

#DrugCompanyPhaseTrials

Flagyl

DDePuy Orthopaedics

Approved

4 2

Neoral

Voltaren

Crestor

Biaxin

Epidiolex

Floxin

1 8

Amoxil

GGlobal Antibiotics Research and Development Partnership

Approved

1 9

Glucophage

EMD Serono

Approved

1 10

Minocin

TTriax

Approved

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Chronic Periodontitis1 trial

Effect of Arthrospira Platensis (Spirulina) as an Adjunct to Scaling and Root Planing on Salivary Antioxidant Levels in Chronic Periodontitis Subjects

Completed·TTatyasaheb Kore Dental College·Phase 4·NCT02886676·70 enrolled

Periodontitis1 trial

Effect of Spirulina on Periodontitis

Completed·KKafrelsheikh University·N/A·NCT06016933·40 enrolled

Beta-Thalassemia1 trial

Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia

Completed·TTanta University·N/A·NCT02671695·40 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Spirulina. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Spirulina compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Spirulina. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Tanta University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: TTanta University

Spirulina

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Chronic Periodontitis1 trial

Periodontitis1 trial

Beta-Thalassemia1 trial

References

Drug Info

Quick Facts

Related News